Zacks.com on MSN16h
Should Edwards Lifesciences Stock Remain in Your Portfolio Now?
EW stock is on investors' radars due to the promising structural heart opportunities following the divestment of the Critical Care arm.
Revolutionary BiVACOR heart device moves to phase 2 of FDA trial
Like all mechanical hearts, BiVACOR currently acts as bridge for patients waiting for a human heart transplant, but its ...